CRG HOLDINGS CO.,LTD. Logo

CRG HOLDINGS CO.,LTD.

Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.

7041 | T

Overview

Corporate Details

ISIN(s):
JP3346110004
LEI:
Country:
Japan
Address:
新宿区西新宿2−1−1
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CRG HOLDINGS CO.,LTD. is a holding company specializing in comprehensive human resource services and diversified business solutions. The company's operations are structured across five key segments. Its core Human Resource business provides IT-driven temporary staffing and personnel placement. The Outsourcing division offers broad support for various business processes. The System Solution segment leverages the group's expertise in recruitment and operational improvement to deliver effective IT solutions. Additionally, the company provides corporate financial services through its Financial division and offers unique M&A and investment advisory services, capitalizing on its extensive background in the human capital industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 08:05
Interim Report
確認書
Japanese 8.9 KB
2025-05-15 08:04
Interim Report
半期報告書-第12期(2024/10/01-2025/09/30)
Japanese 229.3 KB
2024-12-26 04:29
Post-Annual General Meeting Information
臨時報告書
Japanese 25.1 KB
2024-12-26 04:28
Governance Information
内部統制報告書-第11期(2023/10/01-2024/09/30)
Japanese 23.7 KB
2024-12-26 04:28
Registration Form
確認書
Japanese 8.9 KB
2024-12-26 04:27
Registration Form
有価証券報告書-第11期(2023/10/01-2024/09/30)
Japanese 1.2 MB
2024-11-27 07:10
Regulatory News Service
臨時報告書
Japanese 19.5 KB
2024-11-14 08:31
Regulatory News Service
臨時報告書
Japanese 22.5 KB
2024-09-13 08:01
Notice of Dividend Amount
臨時報告書
Japanese 18.8 KB
2024-06-14 08:06
M&A Activity
臨時報告書
Japanese 23.6 KB
2024-05-14 08:09
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-05-14 08:08
Quarterly Report
四半期報告書-第11期第2四半期(2024/01/01-2024/03/31)
Japanese 209.3 KB
2024-04-30 08:13
M&A Activity
臨時報告書
Japanese 35.9 KB
2024-04-26 08:04
Board/Management Information
臨時報告書
Japanese 22.0 KB
2024-02-14 07:03
Report Publication Announcement
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all CRG HOLDINGS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRG HOLDINGS CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CRG HOLDINGS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.